SCHEMBL18152723

SCHEMBL18152723

O=[N+]([O-])c1c(Cc2ccc(F)cc2)c(Br)cc2[nH]nc(F)c12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.35
▸ MAPT P10636 2/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ABCC8 Q09428 1/20 0.33
▸ KCNJ11 Q14654 1/20 0.33
▸ MGMT P16455 1/20 0.33
▸ RIPK1 Q13546 1/20 0.32
▸ KCNJ1 P48048 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ MAP2K4 P45985 1/20 0.32
▸ MDM2 Q00987 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ RET P07949 1/20 0.31
▸ KDR P35968 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18152810 0.76 MDM2 (0.42) HTTMAPTPTGS1PTGS2MGMT
SCHEMBL30811696 0.67 CYP3A4 (0.40) MAPTALDH1A1CYP3A4
SCHEMBL18152696 0.67 RIPK1 (0.37) HTTMAPTMGMTRIPK1SMN1; SMN2
SCHEMBL1250100 0.65 AKR1B1 (0.38) HTTMAPTALDH1A1MAPK1CYP1A2
SCHEMBL18152622 0.65 MGMT (0.39) MAPTMGMTCYP1A2IDO1
SCHEMBL14638102 0.63 HTT (0.44) HTTNPC1RAB9AMGMTKCNJ1
SCHEMBL22655651 0.62 MAPT (0.39) MAPTALDH1A1MAPK1CYP1A2CYP3A4
SCHEMBL4584917 0.62 TDP1 (0.39) HTTMAPTNPC1RAB9AMGMT
SCHEMBL30856168 0.62 CYP1A2 (0.47) MAPTRAB9AALDH1A1MAPK1CYP1A2
SCHEMBL27949168 0.61 LMNA (0.38) HTTPTGS1PTGS2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283077-A2 BROMODOMAIN INHIBITOR Celgene Quanticel Research, Inc. (US) 2018-02-21 — — EP disclosed
WO-2016168682-A2 BROMODOMAIN INHIBITOR CELGENE QUANTICEL RESEARCH, INC. (US) 2016-10-20 — — WO disclosed
Send feedback